GSK (GSK) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook gives a good ...

A new partnership between the University of Oxford and GSK aims to develop vaccines against cancer before develop ...

GSK (GSK) and the University of Oxford announced that they have entered a new research collaboration focused on the potential of cancer ...

As of 24 January at 1:40:49 pm GMT-5. Market open. Adjusted closing price adjusted for splits and dividend and/or capital gain distributions.

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...